Fundamentals of Cardipmetabolic Risk Factor Reduction: Achieving and Maintaining Weight Loss with Pharmacotherapy or Bariatric Surgery

Keyphrases

• Weight Loss 100%
• Pharmacotherapy 100%
• Bariatric Surgery 100%
• Risk Factor Reduction 100%
• United States 66%
• Body Mass Index 66%
• Obesity 66%
• Obese Patients 66%
• Morbid Obesity 66%
• Placebo 33%
• High Prevalence 33%
• In(III) 33%
• Physical Activity 33%
• Medical Complications 33%
• Therapeutic Potential 33%
• Lose Weight 33%
• Long-term Treatment 33%
• Medical Comorbidity 33%
• Causal Relationship 33%
• Health Problems 33%
• Obesity Treatment 33%
• Lifestyle Modification 33%
• Activity Modification 33%
• Lifestyle Intervention 33%
• Long-term Weight Loss 33%
• Behavioral Activity 33%
• Orlistat 33%
• Therapeutic Decision-making 33%
• Anti-obesity 33%
• Therapeutic Lifestyle Changes 33%
• Effective Weight 33%
• Sibutramine 33%

Medicine and Dentistry

• Drug Therapy 100%
• Bariatric Surgery 100%
• Body Mass Index 66%
• Lifestyle Modification 66%
• Prevalence 33%
• Placebo 33%
• Physical Activity 33%
• Morbid Obesity 33%
• Lifestyle Intervention 33%
• Orlistat 33%
• Sibutramine 33%
• Comorbidity 33%
• Diseases 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Pharmacotherapy 100%
• Placebo 33%
• Prevalence 33%
• Morbid Obesity 33%
• Tetrahydrolipstatin 33%
• Sibutramine 33%
• Comorbidity 33%
• Diseases 33%